stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Doctor Care Anywhere Group PLC

United Kingdom · ASX: DOC.AX · Market cap: · P/E: · P/S:

Doctor Care Anywhere runs a digital health service that lets people see a doctor by video or phone, mostly paid for by insurers and employers.

Doctor Care Anywhere is a telehealth company that gives people a way to see a general practitioner without sitting in a waiting room. You open its app, describe what's wrong, and get a video or phone appointment with a doctor, often the same day. It also offers follow-up care, prescriptions, and referrals, plus mental health support. The service is built around the UK and Ireland, and it works a bit like a private online clinic that fits in your pocket.

Doctor Care Anywhere Group PLC (DOC.AX) Private telehealth consultations via its digital health platform: line art illustration of a smartphone showing a video-call consultation screen with a doctor's video panel and chat
Online GP consultations
Patients in the UK see a doctor through a video call on their phone instead of visiting a clinic.

Most of the money comes from selling this service to organizations rather than to individual patients. Private health insurers and corporate clients pay for their members or employees to have access, and then those people use the app when they need a doctor. That model is appealing because the payer is the insurer or the employer, not the person feeling ill. It also means the company's fortunes rise and fall with its deals and renewals with those partners, and it competes with other private healthcare providers and traditional GP services for that business.


The company listed on the ASX, which is unusual for a UK healthcare business, and it raises and spends money like a growth company trying to win partnerships and scale up. Telehealth is a crowded field, and the hard part is proving that the service saves insurers and employers money while keeping patients happy enough to use it again. Its results and share price have been volatile, and like many smaller listed health-tech firms it depends on holding costs down and keeping its partners on board.

Saved answer · last researched 14 Nov 2026